Prevalence of COVID-19 Infection in a Cohort of Patients Infected by the HIV and Patients Taking PrEP

Hôpital Européen Marseille

Status: Unknown

Conditions: Virus-HIV; Covid19

Treatments: Diagnostic Test: Serology test for COVID-19

Study type: Observational

Funder types: Other

Identifiers

NCT04575545

2020-A02018-31

Details and patient eligibility

About

The purpose of the study is to assess seroprevalence of COVID-19 infection in a cohort of HIV + patients and in a cohort of patients taking PrEP by emtricitabine / tenofovir.

Enrollment: 600 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Aged ≥ 18 years
• patients infected by the HIV on treatment
• patients taking PreP (Pre-exposure prophylaxis (PrEP))
• Being affiliated with or benefiting from a social security scheme

Exclusion criteria

• Subject to a measure for the protection of justice

Trial design

600 participants in 2 patient groups

HIV positive patients

Treatment:

Diagnostic Test: Serology test for COVID-19

Patients taking PrEP

Treatment:

Diagnostic Test: Serology test for COVID-19